Share on LinkedIn Share on Twitter Share on Facebook DFIN IPO Report - September 2020 Edition Share on LinkedIn Share on Twitter Share on Facebook Congratulations to the 70 September issuers and their advisors on the successful completion of their IPO. DFIN was proud to have serviced the following: ACON S2 Acquisitions American Well Asana Athira Pharma Boqii Broadstone Net Lease Chindata Corsair Gaming Dyne Therapeutics Equity Distribution Acquisition Executive Network Partner GoodRx Graybug Vision JFrog Laird Superfood Metacrine NavSight Oaktree Acquisition Corp II Orphazyme A/S Outset Medical Pactiv Evergreen Palantir Technologies Peridot Acquisition PMV Pharmaceutical Prelude Therapeutics Stepstone Sumo Logic Taysha Gene Therapies Unity Software VPC Impact Yalla Group "A September to remember....A record-breaking month brings Q-3 to a close with a bang. More PE sponsors participated in SPAC formations lending to the continuation of SPAC mania, giving many private companies an alternative to the traditional IPO route. September also saw a significant number of tech offerings including the direct listing for DFIN client Palantir Technologies." CRAIG CLAY, PRESIDENT, DONNELLEY FINANCIAL SOLUTIONS